Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Eur J Obstet Gynecol Reprod Biol ; 155(2): 204-8, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21193261

ABSTRACT

OBJECTIVE: To evaluate the outcome of CIN 2 diagnosed by colposcopy-directed biopsy in women followed without treatment for 12 months and to verify whether the regression and progression of this lesion are associated with the woman's age at diagnosis and age at first sexual intercourse. STUDY DESIGN: Women diagnosed with CIN 2 by biopsy and with previous cervical smear showing LSIL were included in this cohort study and followed up for one year with cervical smear and colposcopy every three months. The rates of progression, persistence and regression of the CIN 2 were evaluated. The Kruskal-Wallis test was used to analyze the woman's age at diagnosis, age at first sexual intercourse and interval since the first sexual intercourse according to the CIN 2 outcome, assuming a significance level of 5%. RESULTS: At the end of 12 months of follow-up the CIN 2 regression rate was 74% (31/42), progression rate to CIN 3 was 24% (10/42) and in one case CIN 2 persisted (2%). Among women who had regression, this event was detected in the first six months of follow-up in 26 of the 31 cases. There was no statistically significant association between the evolution of CIN 2 and the woman's age at diagnosis, age at first sexual intercourse and interval since first sexual intercourse. Women whose lesions were restricted to one quadrant were more likely to have CIN 2 regression at three-month follow-up compared with women with a lesion extending to one or more quadrants (OR: 6.50; 95% CI: 1.20-35.23). CONCLUSIONS: The results of this study indicate that the majority of CIN 2 diagnosed by biopsy in women with previous Pap smear showing LSIL will regress in 12 months and therefore an expectant approach could be considered in these cases, not only for young women. Nevertheless these findings are not conclusive, and larger studies are required in order to certify when it is safe to adopt expectant management for CIN 2.


Subject(s)
Disease Progression , Neoplasm Regression, Spontaneous , Uterine Cervical Dysplasia/physiopathology , Adolescent , Adult , Age Factors , Biopsy , Carcinoma in Situ/diagnosis , Carcinoma in Situ/physiopathology , Coitus , Colposcopy , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Staging , Papanicolaou Test , Statistics, Nonparametric , Time Factors , Tumor Burden , Vaginal Smears , Young Adult , Uterine Cervical Dysplasia/diagnosis
2.
Gynecol Oncol ; 112(1): 114-8, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19007972

ABSTRACT

OBJECTIVE: HPV-DNA integration is one factor for malignant transformation and can be identified using in situ hybridization (ISH), where a diffuse signal represents episomal HPV and punctate, integrated. The aim is to verify if a punctate pattern could be a marker of CIN1 that progresses. METHODS: 74 CIN1 biopsies were studied. In the follow up, a second biopsy was performed and 65% showed CIN1 or no lesion (group without progression) and 35% CIN2/3 (with progression). ISH was carried out with HR-HPV GenPoint in the first biopsy looking for the positive distribution in epithelium regions (basal, intermediate, superficial) and reaction pattern (diffuse and punctate). The Mann-Whitney and Fisher tests were used to compare the groups (p

Subject(s)
Papillomaviridae/genetics , Papillomavirus Infections/complications , Papillomavirus Infections/virology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Adolescent , Adult , Aged , Biopsy , Cell Transformation, Viral , DNA, Viral/genetics , Disease Progression , Female , Humans , In Situ Hybridization , Middle Aged , Retrospective Studies , Virus Integration , Young Adult
3.
Eur J Obstet Gynecol Reprod Biol ; 139(1): 79-85, 2008 Jul.
Article in English | MEDLINE | ID: mdl-17933453

ABSTRACT

BACKGROUND: The objective of this study was to evaluate the correlation between the 2001 Bethesda classification of endocervical glandular abnormalities and histological diagnosis. STUDY DESIGN: A series of 155 women with endocervical glandular abnormalities on cervical smears were included: 91 with atypical glandular cells (AGC) not otherwise specified (NOS), 15 with AGC-favor neoplastic (FN); 35 with AGC associated with high-grade squamous intraepithelial lesion (HSIL) as combined diagnosis and 14 with adenocarcinoma in situ (AIS). RESULTS: Histological outcome of squamous neoplasias (CIN 2 or worse) and adenocarcinoma were significantly associated with AGC-FN and AIS, taking as reference AGC-NOS, and more associated with AIS than AGC-FN. Similar associations were observed for histological outcome of adenocarcinoma, but no association was observed for only squamous neoplasia. Histological outcome of CIN2 or worse was strongly associated with AGC when HSIL was also present, but no association was observed with only for adenocarcinoma histological outcome. CONCLUSIONS: AGC-NOS, AGC-FN and AIS cytological diagnosis represent a progressively increasing association with neoplastic diagnosis, due to progressively increasing association with adenocarcinoma. Histological outcome of squamous neoplasia is frequent but does not differ with these cytological interpretations. The presence of HSIL associated with AGC represents greater probability of squamous neoplasia but not adenocarcinoma.


Subject(s)
Adenocarcinoma/pathology , Carcinoma, Squamous Cell/pathology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology , Adenocarcinoma/diagnosis , Carcinoma, Squamous Cell/diagnosis , Female , Humans , Uterine Cervical Neoplasms/diagnosis , Vaginal Smears/methods , Uterine Cervical Dysplasia/diagnosis
4.
J Reprod Med ; 51(9): 715-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17039701

ABSTRACT

BACKGROUND: Benign metastasizing leiomyoma (BML) of the lung is a rare manifestation of metastasis from a uterine myoma, in which its benign characteristics are maintained. The majority of cases are asymptomatic. CASES: Case 1 responded to the classic treatment of oophorectomy, after which an improvement in symptoms was achieved. In case 2, however, symptoms appeared following oophorectomy and were treated with raloxifene. CONCLUSION: These cases show the uncertainty that exists with respect to the evolution and treatment of symptomatic BML. Raloxifene is a therapeutic agent that has not been widely studied for this purpose but should be considered for inclusion in the arsenal of therapeutic options available.


Subject(s)
Leiomyomatosis/pathology , Lung Neoplasms/secondary , Lung/pathology , Myometrium/pathology , Uterine Neoplasms/pathology , Adult , Estrogen Antagonists/therapeutic use , Female , Humans , Leiomyomatosis/drug therapy , Leiomyomatosis/surgery , Lung Neoplasms/drug therapy , Lung Neoplasms/surgery , Middle Aged , Ovariectomy , Raloxifene Hydrochloride/therapeutic use , Treatment Outcome
5.
Contraception ; 73(6): 634-40, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16730498

ABSTRACT

OBJECTIVE: This descriptive study evaluated endometrial histology, microvascular density and caliber, and quantification of matrix metalloproteinase (MMP-3) expression in long-term users of the Nestorone (NES)-releasing implant who presented or not endometrial breakthrough bleeding (BTB). METHODS: Endometrial biopsies were obtained from 32 healthy women with unpredictable BTB. The quantitative analysis was performed only in 20 samples. RESULTS: The mean duration of use of the implant among the 14 women with BTB was 19.6+/-1.0 months, and the other six women had used the implant for 17.7+/-2.3 months (mean+/-S.E.M.). Histological analysis of the endometrial tissue showed a predominance of progestogenic pattern followed by atrophic and proliferative endometrium in both groups. Mucosal breakdown and glandular pseudostratification were observed in half of the cases. Endometrial vascular density was 73.1+/-10.0 and 57.5+/-24.1 vessels/mm(2), and maximum vessel diameter was 923.3+/-86.0 and 1038.0+/-404 microm (mean+/-S.E.M.) in the group with and without BTB, respectively, without significance, and the rate of cells expressing MMP-3x1000 counted stromal cells was 155.8+/-24.8 and 127.0+/-19.0 (mean+/-S.E.M.) in both groups, respectively, without significance. CONCLUSIONS: This study provides information about some endometrial aspects of women using NES in contraceptive implants. In addition, the endometrium was similar during long-term use of NES-releasing contraceptive implants in women with and without endometrial bleeding.


Subject(s)
Endometrium/pathology , Matrix Metalloproteinase 3/analysis , Metrorrhagia , Norprogesterones/adverse effects , Adult , Biopsy , Contraceptive Agents, Female/adverse effects , Drug Implants/adverse effects , Endometrium/blood supply , Endometrium/drug effects , Endometrium/enzymology , Female , Humans , Metrorrhagia/chemically induced , Microcirculation/drug effects , Norprogesterones/administration & dosage
6.
Hum Reprod ; 19(8): 1778-84, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15192067

ABSTRACT

BACKGROUND: The main reason for discontinuation of the levonorgestrel-releasing intrauterine system (LNG-IUS) is unpredictable bleeding pattern. METHODS: The objective of the study was to evaluate the endometrial histology, microvascular density and calibre, and the quantification of matrix metalloproteinase (MMP-3) in long-term users of LNG-IUS, with and without bleeding. Endometrial biopsies were obtained from 58 healthy women, 29 who maintained some degree of endometrial bleeding and 29 who were amenorrhoeic. RESULTS: In the histological analysis, the majority of samples displayed a progestin-modified appearance. The major glandular diameter and the perimeter were significantly greater in the group of women with amenorrhoea. A significantly higher number of leukocytes was found in the group with bleeding (P = 0.014). No significant correlation was observed between the microvascular density or calibre and the bleeding pattern. MMP-3 showed a significantly higher number of reactive cells (P = 0.005) in the group who maintained some degree of bleeding. CONCLUSIONS: Women using LNG-IUS who maintained endometrial bleeding during its use presented a higher number of leukocytes and MMP-3 in the endometrium when compared to women using LNG-IUS who became amenorrhoeic. However, the results did not provide evidence for microvascular pattern changes.


Subject(s)
Amenorrhea/pathology , Contraceptive Agents, Female/adverse effects , Endometrium/pathology , Levonorgestrel/adverse effects , Matrix Metalloproteinase 3/metabolism , Menstruation/drug effects , Adult , Amenorrhea/metabolism , Biopsy , Contraceptive Agents, Female/administration & dosage , Endometrium/blood supply , Endometrium/enzymology , Female , Humans , Leukocytes/pathology , Levonorgestrel/administration & dosage , Microcirculation/drug effects , Microcirculation/pathology , Stromal Cells/enzymology
7.
Rev. bras. ginecol. obstet ; 22(2): 65-70, mar. 2000. tab
Article in Portuguese | LILACS | ID: lil-324020

ABSTRACT

Objetivos: avaliar a utilização da conização por cirurgia de alta freqüência por alça (CAF) na neoplasia intra-epitelial cervical (NIC), a importância do comprometimento das margens de ressecção e o seguimento das pacientes. Métodos: foram avaliadas 95 mulheres submetidas à CAF por NIC entre janeiro de 1996 e dezembro de 1997. Para análise estatística, utilizamos o coeficiente de concordância kappa e o teste de tendência de Cochran Armitage. Resultados: dos 63 casos submetidos à biópsia dirigida antes da conização, o cone por CAF apresentou lesões mais graves que a biópsia em 24 casos, sendo um caso microinvasor, e em 8 mulheres a biópsia eliminou a lesão. Entre as pacientes submetidas à conização com biópsia prévia compativel com cervicite ou NIC 1, 14 / 25 (56 por cento) apresentavam NIC 2 ou 3. Das 32 mulheres que não tinham biópsia prévia, 15 apresentavam NIC 2 ou 3, e quatro, carcinoma microinvasor no cone. Em relação às margens do cone, 25 casos (26 por cento) apresentaram margens endocervicais comprometidas e quanto maior o grau da lesão cervical maior a possibilidade de presença de lesão nas margens (p =0,024). Dessas pacientes, 2 de 10 submetidas a novo procedimento apresentavam doença residual na peça cirúrgica. Entre as 70 pacientes com margens livres foram realizadas três conizações a frio e uma histerectomia e duas apresentavam doença residual na peça cirúrgica. Conclusões: a conização por CAF sem biópsia prévia depende da combinação entre o diagnóstico citológico e a experiência do colposcopista e, em princípio, deve ser reservada para os casos em que a colpocitologia e a colposcopia são concordantes e compatíveis com NIC 2 ou 3. Por outro lado, a ampliação cirurgica pós-CAF no tratamento da NIC não é determinada exclusivamente pelo comprometimento das margens, mas sim pelo seguimento, excluindo-se os casos de microinvasão e lesões glandulares que se beneficiam com a avaliação histológica posterior


Subject(s)
Humans , Female , Adult , Middle Aged , Uterine Cervical Dysplasia , Biopsy , Colposcopy
SELECTION OF CITATIONS
SEARCH DETAIL
...